-
Maternal Surgery, Calpain, and Offspring Cognition
2026-09-24
A pregnant-rat study links maternal non-obstetric surgery to excess hippocampal calpain activity, disrupted BDNF/TrkB signaling, and cognitive deficits in offspring. Postnatal treatment with MDL 28170 or a TrkB agonist partially improved behavioral and neural outcomes, supporting a mechanistic connection while leaving important questions about specificity and translation unresolved.
-
Linoleic Acid: From Lipid Stress to Translational Control
2026-09-23
Linoleic Acid is a useful experimental input for studying membrane biology, oxidative injury, and epithelial migration—but its effects depend on preparation, context, and careful controls. This article connects those established research applications with recent findings on fatty-acid signaling and translatome remodeling, while distinguishing what the evidence supports from what remains to be tested.
-
TaqI Restriction Endonuclease: Digestion Guide
2026-09-23
TaqI Restriction Endonuclease (SKU K3053) provides rapid, sequence-specific cleavage of plasmid DNA, PCR products, and genomic DNA containing the 5′-TCGA-3′ recognition site. It is intended for controlled research workflows such as cloning and gel analysis, not for diagnostic, clinical, or medical use.
-
Oxaliplatin Resistance: Designing Better Assays
2026-09-22
Oxaliplatin is a platinum-based chemotherapeutic agent whose DNA damage response depends on cellular context. This guide translates resistance biology, CDK1–PARP1 findings, and model selection into more informative cancer chemotherapy assays.
-
ApexPrep DNA Plasmid Miniprep Kit for AML Research
2026-09-22
Build cleaner cloning, sequencing, and transformation workflows around reproducible plasmid recovery from high- and low-copy vectors. The ApexPrep DNA Plasmid Miniprep Kit connects practical alkaline lysis optimization with assay planning for AML transcription-factor studies, while keeping sequence verification and cell-specific validation in view.
-
Oxaliplatin in Tumor–Stroma Drug Testing
2026-09-21
Oxaliplatin is a platinum-based chemotherapeutic agent whose DNA damage response can be studied more realistically in patient-derived tumor–stroma assembloids. This guide translates recent gastric cancer modeling findings into practical assay design, compound handling, and interpretation strategies.
-
Carbapenemase Gene Transmission in CREC
2026-09-21
Chen et al. characterized carbapenemase-encoding genes in 54 carbapenem-resistant Enterobacter cloacae isolates from eight teaching hospitals in Guangdong, combining plasmid elimination, PCR, susceptibility testing, conjugation, mobile-element analysis, and ERIC-PCR genotyping. The study shows that blaNDM-1 was frequently plasmid-associated and readily transferable, linking multidrug resistance with both horizontal gene mobility and possible clonal dissemination.
-
HNF4A-AS1 and Sorafenib Resistance in HCC
2026-09-20
This Theranostics study identifies liver-enriched lncRNA HNF4A-AS1 as a regulator of sorafenib-induced ferroptosis in hepatocellular carcinoma through METTL3/YTHDF3-dependent control of DECR1 and PUFA metabolism. Its integrated use of public datasets, lipidomics, molecular assays, organoids, and xenografts provides a mechanistic framework for studying metabolic drivers of drug resistance.
-
Chloramphenicol for Plasmid Selection
2026-09-19
Build more reproducible plasmid-selection assays with a defined 50S ribosomal inhibitor, concentration strategy, and confirmation workflow. Learn how Chloramphenicol can complement plasmid-transfer studies without substituting for PCR or genotypic resistance analysis.
-
Pronase E for Ferroptosis Proteomics
2026-09-18
Learn how to use Pronase E as a broad-spectrum protease mixture for target-engagement, surface-protein, and proteomic workflows inspired by ferroptosis research. The guide emphasizes fresh reagent preparation, controlled digestion, assay-specific controls, and troubleshooting for reproducible results.
-
Hypoxia and Immunometabolism in the Tumor Microenvironment
2026-09-18
This review presents tumor hypoxia and immunometabolism as a coupled system in which oxygen limitation, nutrient competition, and immune-cell dysfunction reinforce an immunosuppressive tumor microenvironment. Its main practical contribution is a framework for connecting HIF signaling and metabolic adaptation with immune evasion, while identifying opportunities and limitations for metabolism- and hypoxia-directed therapeutic research.
-
Chloramphenicol: Mechanism and Plasmid Selection
2026-09-17
Chloramphenicol is a bacterial 50S ribosomal inhibitor used in molecular biology and plasmid selection assays. Its documented concentration, solubility, and storage parameters support reproducible workflows, while recent plasmid-transmission data show why antibiotic selection should not be treated as a substitute for genotypic confirmation.
-
ApexPrep DNA Plasmid Miniprep Kit for AML Assays
2026-09-17
Build reproducible plasmid workflows for AML gene-regulation studies, from cloning and sequence verification to robust-cell-line transfection. The ApexPrep DNA Plasmid Miniprep Kit combines alkaline lysis with membrane-based cleanup to support high- and low-copy constructs in one streamlined preparation.
-
Obeticholic Acid: An FXR Strategy for Liver Fibrosis
2026-09-16
A mechanism-focused guide to using Obeticholic Acid as an FXR probe in liver fibrosis, bile acid, inflammation, and portal-pressure research, with practical validation strategies and translational guardrails.
-
MK-8745: Reading Aurora A Biology in Cancer Models
2026-09-16
MK-8745 is a potent, selective Aurora A inhibitor for connecting mitotic arrest with apoptosis, genotype, and tumor pathology. This article presents an evidence-based assay framework for interpreting Aurora A dependence across cell-based, lymphoma, xenograft, and retinoblastoma research.